US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

63.63

+0.07440.12%

Post-market: 63.50-0.1290-0.20%16:10 EDT

Volume:9K

Turnover:589.16K

Market Cap:274.88M

PE:20.81

High:63.63

Open:63.27

Low:62.99

Close:63.55

52wk High:64.10

52wk Low:39.10

Shares:4.32M

Float Shares:4.32M

Volume Ratio:0.27

T/O Rate:0.22%

Dividend:1.53

Dividend Rate:2.40%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Immunovant Director Atul Pande Disposes of 1,500 Common Shares for $59,700

Revolution Medicines (RVMD) Is Up 5.3% After FDA Priority Review For Pancreatic Cancer Drug Approval Bid

Simply Wall St.

Immunovant Updates Financial Calendar with First-quarter Results Release and Business Update Call

Roivant to Report Q1 Results, Host Conference Call and Webcast

Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

THOMSON REUTERS

Revolution Medicines Inc : Wedbush Raises Target Price to $192.1 from $181

THOMSON REUTERS

Revolution Medicines receives FDA review acceptance for daraxonrasib

Revolution Medicines Says FDA Accepts Daraxonrasib NDA for Previously Treated Metastatic Pancreatic Cancer

Immunovant Announces Annual Shareholder Meeting

Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer

THOMSON REUTERS

BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1

Is BrightSpring Health Services (BTSG) Undervalued On Its Move Into The S&P 400?

Simply Wall St.

Does BrightSpring’s S&P 400 Reclassification Alter the Bull Case for BrightSpring Health Services (BTSG)?

Simply Wall St.

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64

Shanghai Launches Pilot for Streamlined Import of Medical Device Production Materials

Chison Medical's Self-Developed Breast AI Ultrasound Robot Secures Pioneering Medical Device Test Report

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents

MT Newswires Live

Guardant Health is Maintained at Buy by Guggenheim

Guardant Health price target raised to $190 from $160 at Guggenheim

Revolution Medicines Inc : JP Morgan Raises Target Price to $205 from $200

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PTH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":63.629,"timestamp":1787774400000,"preClose":63.5546,"halted":0,"volume":9295,"hourTrading":{"tag":"盘后","latestPrice":63.5,"preClose":63.629,"latestTime":"16:10 EDT","volume":19,"amount":1212.3165,"timestamp":1787775005417,"change":-0.129,"changeRate":-0.002027,"amplitude":0},"delay":0,"changeRate":0.0011706469712656068,"floatShares":4320000,"shares":4320000,"eps":3.057033,"marketStatus":"Not Yet Opened","change":0.0744,"latestTime":"08-26 16:00:00 EDT","open":63.27,"high":63.629,"low":62.985,"amount":589164,"amplitude":0.010133,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":63.5546,"sharesOutstanding":2480000,"nav":63.56092,"aum":280939266.4,"dividendRate":0.023972,"bidAskSpread":0.002223,"preHourTrading":{"tag":"盘前","latestPrice":63.5546,"preClose":63.5546,"latestTime":"07:01 EDT","volume":1,"amount":63.5546,"timestamp":1787742068433,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":63.5,"preClose":63.629,"latestTime":"16:10 EDT","volume":19,"amount":1212.3165,"timestamp":1787775005417,"change":-0.129,"changeRate":-0.002027,"amplitude":0},"volumeRatio":0.26737,"impliedVol":0.0861,"impliedVolPercentile":0.2629},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4320000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.26737,"shares":4320000,"dividePrice":1.5253,"high":63.629,"amplitude":0.010133,"preClose":63.5546,"low":62.985,"week52Low":39.1,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":63.629,"eps":3.057033,"divideRate":0.023972,"volume":9295,"delay":0,"ttmEps":3.057033,"open":63.27,"prevYearClose":49.701,"prevWeekClose":62.9761,"prevMonthClose":58.0963,"prevQuarterClose":59.76,"fiveDayClose":64.0724,"twentyDayClose":57.08,"sixtyDayClose":50.8485},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654619030","title":"Immunovant Director Atul Pande Disposes of 1,500 Common Shares for $59,700","url":"https://stock-news.laohu8.com/highlight/detail?id=2654619030","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654619030?lang=en_us&edition=fundamental","pubTime":"2026-07-25 05:59","pubTimestamp":1784930385,"startTime":"0","endTime":"0","summary":"Immunovant director Atul Pande disposes of 1,500 common shares for $59,700Immunovant director Atul Pande sold 1,500 shares on July 24, 2026 at USD 39.8.The sale followed the exercise of stock options ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDLbGPzpM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IMVT","PTH","BK4139","ROIV","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653770581","title":"Revolution Medicines (RVMD) Is Up 5.3% After FDA Priority Review For Pancreatic Cancer Drug Approval Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2653770581","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653770581?lang=en_us&edition=fundamental","pubTime":"2026-07-24 11:33","pubTimestamp":1784864028,"startTime":"0","endTime":"0","summary":"Revolution Medicines previously announced that the U.S. FDA accepted for review its New Drug Application for daraxonrasib, an oral RAS(ON) multi-selective inhibitor for previously treated metastatic pancreatic ductal adenocarcinoma, supported by Phase 3 RASolute 302 data showing improved overall and progression-free survival versus standard chemotherapy.\nThe drug’s Breakthrough Therapy and Orphan Drug designations, together with inclusion in the FDA Commissioner’s National Priority Voucher...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-rvmd-is-up-53-after-fda-priority-review","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-rvmd-is-up-53-after-fda-priority-review","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4141","BK4139","IDNA","LU1548497426.USD","LU1720051108.HKD","LU1861214812.USD","IE0009354923.USD","LU0109394709.USD","PTH","LU2360107325.USD","IE0002141913.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1983260115.SGD","LU2298322129.HKD","IE00BD6J9T35.USD","IE00BZ199S13.USD","LU1854103824.USD","CANC","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4605","LU1861219969.SGD","IE00BFMHRM44.USD","LU0320765992.SGD","BK4512","LU0348723411.USD","LU0724618433.USD","LU1854104046.USD","LU1861215975.USD","BK4585","LABU","LU0124384867.USD","LU1861220033.SGD","BBH","LU1720051017.SGD","LU1978683503.SGD","IE0009355771.USD","RVMD","LU2357305700.SGD","IE00BFTCPJ56.SGD","ON","IE00B2B36J28.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653490775","title":"Immunovant Updates Financial Calendar with First-quarter Results Release and Business Update Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2653490775","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653490775?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:26","pubTimestamp":1784838369,"startTime":"0","endTime":"0","summary":"Immunovant updates financial calendar with first-quarter results release and business update callImmunovant to report fiscal Q1 results for the period ended June 30, 2026 on Aug. 6, 2026, before the m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL78ZZLp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","PTH","BCDF","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","BK4007","SG9999014005.SGD","NDAQ","SG9999014021.USD","IMVT","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014013.SGD","ROIV","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653775918","title":"Roivant to Report Q1 Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2653775918","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653775918?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:20","pubTimestamp":1784838053,"startTime":"0","endTime":"0","summary":"Roivant to report Q1 results, host conference call and webcastRoivant schedules an 8:00 a.m. ET conference call webcast on Aug. 6, 2026 to report Q1 results ended June 30, 2026.Disclaimer:This news br","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL1SxkLW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","BCDF","PTH","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014039.USD","BK4007","BK4588","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","LU2210150020.SGD","LU2210149790.SGD","BK4139","ROIV","IE00BKPKM429.USD","LU2095319765.USD","SG9999014005.SGD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653773663","title":"Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2653773663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653773663?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:05","pubTimestamp":1784837100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nTUA2MLPQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","ROIV","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653441367","title":"Revolution Medicines Inc : Wedbush Raises Target Price to $192.1 from $181","url":"https://stock-news.laohu8.com/highlight/detail?id=2653441367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653441367?lang=en_us&edition=fundamental","pubTime":"2026-07-23 19:13","pubTimestamp":1784805194,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P0XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDNA","IE0002141913.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","BBH","RVMD","CANC","IE00B2B36J28.USD","IE0009354923.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","PTH","BK4139","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653796206","title":"Revolution Medicines receives FDA review acceptance for daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2653796206","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653796206?lang=en_us&edition=fundamental","pubTime":"2026-07-23 05:05","pubTimestamp":1784754334,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration accepted for review the company’s new drug application for daraxon...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-receives-fda-review-acceptance-for-daraxonrasib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-receives-fda-review-acceptance-for-daraxonrasib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","LABU","LU0889565916.HKD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","BK4588","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4585","BK4139","IE0009354923.USD","IDNA","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","PTH","IE00BJT1NW94.SGD","LU0320765992.SGD","BBH","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653798724","title":"Revolution Medicines Says FDA Accepts Daraxonrasib NDA for Previously Treated Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2653798724","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653798724?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:11","pubTimestamp":1784751111,"startTime":"0","endTime":"0","summary":"Revolution Medicines says FDA accepts daraxonrasib NDA for previously treated metastatic pancreatic cancerRevolution Medicines’ NDA for daraxonrasib in previously treated metastatic pancreatic ductal ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL71TRHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BBH","IE00B4R5TH58.HKD","SG9999014005.SGD","IE00BN0W2T93.GBP","IE00BJJMRZ35.SGD","LU0109394709.USD","LU2095319765.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU0889565916.HKD","LU2210150020.SGD","BCDF","RVMD","SG9999014013.SGD","BK4588","IE0002141913.USD","SG9999014021.USD","IDNA","IE00BGHQF748.EUR","IE00BFTCPJ56.SGD","IE00BN0W2W23.USD","IE0009354923.USD","IE0009355771.USD","PTH","SG9999014039.USD","IE00B64PRP62.GBP","LU0314104364.USD","BK4112","LU0320765992.SGD","IE00B3QW5Z07.USD","NDAQ","IE00BJT1NW94.SGD","CANC","IE00BN0W2V16.EUR","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653979877","title":"Immunovant Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2653979877","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653979877?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:11","pubTimestamp":1784751092,"startTime":"0","endTime":"0","summary":"Immunovant announces annual shareholder meetingImmunovant will hold its annual stockholders meeting virtually on Sept. 2, 2026.Shareholders will vote on electing three directors: Jacob Bauer, Douglas ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL5k6tVV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","ROIV","IMVT","BK4007","PTH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653779866","title":"Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2653779866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653779866?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:05","pubTimestamp":1784750700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA1HDNRD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CANC","LU0109394709.USD","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IDNA","IE00BJJMRZ35.SGD","PTH","IE00B4R5TH58.HKD","IE0009354923.USD","IE0009355771.USD","LU0889565916.HKD","BBH","BK4139","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653556757","title":"BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1","url":"https://stock-news.laohu8.com/highlight/detail?id=2653556757","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653556757?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:30","pubTimestamp":1784719800,"startTime":"0","endTime":"0","summary":"- PDUFA target action date of May 8, 2027 - If approved, encaleret will be the first and only approved therapy specifically indicated for individuals living with ADH1, representing a potential blockbu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/22/3331254/0/en/BridgeBio-Announces-FDA-Acceptance-of-NDA-for-Encaleret-for-ADH1.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4081","SPRE","BK4183","LABU","MAA","PTH","BK4215","BK4585","ENDO","EMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652225114","title":"Is BrightSpring Health Services (BTSG) Undervalued On Its Move Into The S&P 400?","url":"https://stock-news.laohu8.com/highlight/detail?id=2652225114","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652225114?lang=en_us&edition=fundamental","pubTime":"2026-07-19 18:20","pubTimestamp":1784456408,"startTime":"0","endTime":"0","summary":"Index reshuffle puts BrightSpring Health Services in focus\nBrightSpring Health Services (BTSG) moved from the S&P 600 to the S&P 400 Health Care index, a reshuffle that can change how index funds and institutional investors trade the stock.\nSee our latest analysis for BrightSpring Health Services.\nBrightSpring Health Services has seen strong momentum build, with an 84.09% year to date share price return and a very large 254.42% 1 year total shareholder return. The latest index shift and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/is-brightspring-health-services-btsg-undervalued-on-its-move","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/is-brightspring-health-services-btsg-undervalued-on-its-move","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","LU2089984988.USD","BK4585","SPHQ","LU2468319806.SGD","BK4196","PSCH","PTH","BK4588","BTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652235806","title":"Does BrightSpring’s S&P 400 Reclassification Alter the Bull Case for BrightSpring Health Services (BTSG)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2652235806","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652235806?lang=en_us&edition=fundamental","pubTime":"2026-07-18 07:23","pubTimestamp":1784330616,"startTime":"0","endTime":"0","summary":"On 14 July 2026, BrightSpring Health Services, Inc. was removed from the S&P 600 indexes and added to the S&P 400 and S&P 400 Health Care sector, reflecting a reclassification of the company within the S&P index family.\nThis shift into the mid-cap S&P 400 bracket may broaden BrightSpring’s exposure to institutional investors that benchmark against larger, more widely followed indices.\nNext, we’ll examine how BrightSpring’s move into the S&P 400 could influence its existing investment...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/does-brightsprings-sp-400-reclassification-alter-the-bull-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-btsg/brightspring-health-services/news/does-brightsprings-sp-400-reclassification-alter-the-bull-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2468319806.SGD","PTH","LU2089984988.USD","BTSG","PSCH","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652278224","title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2652278224","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652278224?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:57","pubTimestamp":1784235433,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa disposes of 116 common shares worth $18,941.64Guardant Health director Tariq Musa cut his stake to 11,182 shares following a sale disclosed in a Form 4.Musa sold 11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDLc18J55:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK4535","LU0109394709.USD","EKG","HELX","GH","PTH","BK4585","BK4588","GDOC","LU0320765992.SGD","LU0889565916.HKD","BK4551","GNOM","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134717301","title":"Shanghai Launches Pilot for Streamlined Import of Medical Device Production Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=1134717301","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134717301?lang=en_us&edition=fundamental","pubTime":"2026-07-16 23:41","pubTimestamp":1784216466,"startTime":"0","endTime":"0","summary":"Shanghai Customs and the Shanghai Municipal Science and Technology Commission have issued a joint announcement to initiate a pilot program for facilitating the import of production materials for...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","BK1574","HART","MDEV","RSPH","09996","BK1583","MEDX","BK1100","PTH","GDOC","159883","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189914565","title":"Chison Medical's Self-Developed Breast AI Ultrasound Robot Secures Pioneering Medical Device Test Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1189914565","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189914565?lang=en_us&edition=fundamental","pubTime":"2026-07-16 22:01","pubTimestamp":1784210486,"startTime":"0","endTime":"0","summary":"On July 16th, Chison Medical Technologies Co.,Ltd. (ASX: 688358) responded to investor inquiries via an interactive platform, announcing that its independently developed \"Breast AI Ultrasound Robot\"...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NJUL","LCLG","PSQ","PTH","NAPR","688358","AIFD","ARTY","BK1574","09996","CPNQ","MEDX","QMAR","VUSE","TARK","07261","QLD","SQQQ","AGNG","03034","03086","BK1100","GDOC","NOCT","TQQY","TQQQ","159883","QSWN","MVPS","QID","02834","BK1583","RSPH","CHAT","BK0251","HART","09086","QQA","QQQ","GPIQ","BK4593","NJAN","NEWZ","07568","AGIX","OGIG","KOMP","GK","09834","FWD","ROBO","AIBU","03455","161631","QDEC","07266","MDEV","QQQM","NBDS","07522","QTOC","QQQX","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651417554","title":"Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents","url":"https://stock-news.laohu8.com/highlight/detail?id=2651417554","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651417554?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:16","pubTimestamp":1784204172,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma  and its licensee Genevant Sciences, a subsidiary of Roivant Sciences , said Thursday they have filed three international patent infringement lawsuits against Pfizer , BioNTech  over lipid nanoparticle technology used in mRNA COVID-19 vaccines.The companies said they are seeking monetary damages and permanent injunctions covering Pfizer-BioNTech's COVID-19 vaccines and other allegedly infringing products.The new actions expand their existing US patent litigation in New Jersey involving five patents, they said.Separately, Arbutus said it received about $178 million from Moderna  on July 8 as its part of a global patent settlement and expects to receive a dividend from Genevant's parent in Q3.The company said it plans to return capital to shareholders through share repurchases of up to $230 million starting in Q3.Arbutus Biopharma shares were 3.7% higher in premarket trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","SG9999002232.USD","LU1066053197.SGD","LU1894683264.USD","IE00BBT3K403.USD","BK4535","LU0058720904.USD","MRNA","SG9999011175.SGD","SG9999013999.USD","BK4550","BK4533","IE00BLSP4239.USD","LU1894683348.USD","SG9999001176.USD","MRNY","BK4585","OZEM","LU0456855351.SGD","LU0985481810.HKD","LU0122379950.USD","LU1023059063.AUD","PTH","BK4568","IE0002270589.USD","BK4599","IE00B3T34201.USD","IE00BLSP4452.SGD","LU0868494617.USD","LGHT","LU1883839398.USD","SGXZ57979304.SGD","LU0234572021.USD","SG9999003800.SGD","LU0321505868.SGD","BNTX","ABUS","BK4007","BK4588","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","BK4548","IE00B19Z3581.USD","LU0225284248.USD","SG9999001176.SGD","BK4139","LU0225771236.USD","ROIV","LU1057294990.SGD","BK4532","LU0170899867.USD","LU0306806265.USD","LU0321505439.SGD","MRNX","PFE","LU0306807586.USD","BK4501","SG9999002224.SGD","GNOM","BK4551","BK4592","BK4581","IDNA","LU2596442595.SGD","LU0289739699.SGD","WDNA","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651290441","title":"Guardant Health is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651290441","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651290441?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:10","pubTimestamp":1784203800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 16, 2026 08:10 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","BK4585","LU0320765992.SGD","PTH","LU0109394709.USD","BK4551","GNOM","LFSC","GH","LU0889565916.HKD","BK4588","EKG","GDOC","BK4535","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651344620","title":"Guardant Health price target raised to $190 from $160 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651344620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651344620?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199651,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Guardant Health (GH) to $190 from $160 and keeps a Buy rating on the shares. The firm says its Q2 web ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","BK4196","BK4551","LU0889565916.HKD","HELX","EKG","BK4535","BK4585","GDOC","GH","BK4588","GNOM","PTH","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651410809","title":"Revolution Medicines Inc : JP Morgan Raises Target Price to $205 from $200","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651410809?lang=en_us&edition=fundamental","pubTime":"2026-07-16 17:04","pubTimestamp":1784192680,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43I0XC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","BBH","IE0009354923.USD","RVMD","BK4139","IE0002141913.USD","IDNA","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","CANC","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","PTH","IE00B2B36J28.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}